Literature DB >> 33406683

Uremic Sarcopenia and Its Possible Nutritional Approach.

Annalisa Noce1, Giulia Marrone1,2, Eleonora Ottaviani1, Cristina Guerriero1, Francesca Di Daniele1,2, Anna Pietroboni Zaitseva1, Nicola Di Daniele1.   

Abstract

Uremic sarcopenia is a frequent condition present in chronic kidney disease (CKD) patients and is characterized by reduced muscle mass, muscle strength and physical performance. Uremic sarcopenia is related to an increased risk of hospitalization and all-causes mortality. This pathological condition is caused not only by advanced age but also by others factors typical of CKD patients such as metabolic acidosis, hemodialysis therapy, low-grade inflammatory status and inadequate protein-energy intake. Currently, treatments available to ameliorate uremic sarcopenia include nutritional therapy (oral nutritional supplement, inter/intradialytic parenteral nutrition, enteral nutrition, high protein and fiber diet and percutaneous endoscopic gastrectomy) and a personalized program of physical activity. The aim of this review is to analyze the possible benefits induced by nutritional therapy alone or in combination with a personalized program of physical activity, on onset and/or progression of uremic sarcopenia.

Entities:  

Keywords:  hemodialysis; intra-dialytic parenteral nutrition; nutritional supplementation; physical activity; uremic sarcopenia; ω-3 polyunsaturated fatty acids

Mesh:

Substances:

Year:  2021        PMID: 33406683      PMCID: PMC7824031          DOI: 10.3390/nu13010147

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  167 in total

1.  Executive summary--Biomarkers of Nutrition for Development: Building a Consensus.

Authors:  Daniel J Raiten; Sorrel Namasté; Bernard Brabin; Gerald Combs; Mary R L'Abbe; Emorn Wasantwisut; Ian Darnton-Hill
Journal:  Am J Clin Nutr       Date:  2011-07-06       Impact factor: 7.045

2.  Effect of the omega-3 fatty acid plus vitamin E supplementation on subjective global assessment score, glucose metabolism, and lipid concentrations in chronic hemodialysis patients.

Authors:  Zatollah Asemi; Alireza Soleimani; Fereshteh Bahmani; Hossein Shakeri; Navid Mazroii; Fatemeh Abedi; Melika Fallah; Ali Akbar Mohammadi; Ahmad Esmaillzadeh
Journal:  Mol Nutr Food Res       Date:  2015-11-23       Impact factor: 5.914

3.  Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass.

Authors:  Liping Zhang; Jenny Pan; Yanjun Dong; David J Tweardy; Yanlan Dong; Giacomo Garibotto; William E Mitch
Journal:  Cell Metab       Date:  2013-09-03       Impact factor: 27.287

Review 4.  Nutrition and physical activity in CKD patients.

Authors:  Adamasco Cupisti; Claudia D'Alessandro; Giordano Fumagalli; Valentina Vigo; Mario Meola; Caterina Cianchi; Maria F Egidi
Journal:  Kidney Blood Press Res       Date:  2014-07-29       Impact factor: 2.687

5.  Effect of Moderate Aerobic Exercise Training on Endothelial Function and Arterial Stiffness in CKD Stages 3-4: A Randomized Controlled Trial.

Authors:  Amaryllis H Van Craenenbroeck; Emeline M Van Craenenbroeck; Katrijn Van Ackeren; Christiaan J Vrints; Viviane M Conraads; Gert A Verpooten; Evangelia Kouidi; Marie M Couttenye
Journal:  Am J Kidney Dis       Date:  2015-05-08       Impact factor: 8.860

Review 6.  Measuring cachexia-diagnostic criteria.

Authors:  Rony Dev
Journal:  Ann Palliat Med       Date:  2018-09-07

7.  Outcomes associated with intradialytic oral nutritional supplements in patients undergoing maintenance hemodialysis: a quality improvement report.

Authors:  Eduardo Lacson; Weiling Wang; Barbara Zebrowski; Rebecca Wingard; Raymond M Hakim
Journal:  Am J Kidney Dis       Date:  2012-05-24       Impact factor: 8.860

8.  Intradialytic Resistance Training Improves Functional Capacity and Lean Mass Gain in Individuals on Hemodialysis: A Randomized Pilot Trial.

Authors:  Lorena Cristina Curado Lopes; João Felipe Mota; Jonato Prestes; Raquel Machado Schincaglia; Debora Mendes Silva; Nayara Pedatella Queiroz; Ana Tereza Vaz de Souza Freitas; Fábio Santos Lira; Maria do Rosário Gondim Peixoto
Journal:  Arch Phys Med Rehabil       Date:  2019-07-03       Impact factor: 3.966

Review 9.  Frailty in elderly people.

Authors:  Andrew Clegg; John Young; Steve Iliffe; Marcel Olde Rikkert; Kenneth Rockwood
Journal:  Lancet       Date:  2013-02-08       Impact factor: 79.321

10.  Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3-5 chronic kidney disease.

Authors:  Jasmine D Kerr; Rachel M Holden; Alexander R Morton; Robert L Nolan; Wilma M Hopman; Cynthia M Pruss; Jocelyn S Garland
Journal:  BMC Nephrol       Date:  2013-01-26       Impact factor: 2.388

View more
  10 in total

1.  Dietary Inflammatory Potential Is Associated With Sarcopenia Among Chronic Kidney Disease Population.

Authors:  Ying Huang; Mengru Zeng; Lei Zhang; Jingzheng Shi; Yuan Yang; Fuyou Liu; Lin Sun; Li Xiao
Journal:  Front Nutr       Date:  2022-05-11

Review 2.  Obesity-Related Chronic Kidney Disease: Principal Mechanisms and New Approaches in Nutritional Management.

Authors:  Alessandra Stasi; Carmela Cosola; Gianvito Caggiano; Maria Teresa Cimmarusti; Rita Palieri; Paola Maria Acquaviva; Gloria Rana; Loreto Gesualdo
Journal:  Front Nutr       Date:  2022-06-24

3.  Nutritional Status and Other Clinical Variables Are Associated to the Resting Energy Expenditure in Patients With Chronic Kidney Disease: A Validity Study.

Authors:  Samuel Ramos-Acevedo; Luis Rodríguez-Gómez; Sonia López-Cisneros; Ailema González-Ortiz; Ángeles Espinosa-Cuevas
Journal:  Front Nutr       Date:  2022-05-18

4.  Sarcopenia in Non-Dialysis Chronic Kidney Disease Patients: Prevalence and Associated Factors.

Authors:  Geraldo José de Amorim; Cinthia Katiane Martins Calado; Bruno Carlos Souza de Oliveira; Renata Patricia Oliveira Araujo; Tayrine Ordonio Filgueira; Matheus Santos de Sousa Fernandes; Angela Castoldi; Gisele Vajgel; Lucila Maria Valente; José Luiz de Lima-Filho; Paulo Roberto Cavalcanti Carvalho; Fabricio Oliveira Souto
Journal:  Front Med (Lausanne)       Date:  2022-04-07

Review 5.  Gut Dysbiosis and Western Diet in the Pathogenesis of Essential Arterial Hypertension: A Narrative Review.

Authors:  Maria Paola Canale; Annalisa Noce; Manuela Di Lauro; Giulia Marrone; Maria Cantelmo; Carmine Cardillo; Massimo Federici; Nicola Di Daniele; Manfredi Tesauro
Journal:  Nutrients       Date:  2021-04-01       Impact factor: 5.717

6.  Usefulness of Extra Virgin Olive Oil Minor Polar Compounds in the Management of Chronic Kidney Disease Patients.

Authors:  Annalisa Noce; Giulia Marrone; Silvia Urciuoli; Francesca Di Daniele; Manuela Di Lauro; Anna Pietroboni Zaitseva; Nicola Di Daniele; Annalisa Romani
Journal:  Nutrients       Date:  2021-02-10       Impact factor: 5.717

Review 7.  Natural Bioactive Compounds Useful in Clinical Management of Metabolic Syndrome.

Authors:  Annalisa Noce; Manuela Di Lauro; Francesca Di Daniele; Anna Pietroboni Zaitseva; Giulia Marrone; Patrizia Borboni; Nicola Di Daniele
Journal:  Nutrients       Date:  2021-02-16       Impact factor: 5.717

8.  Sarcopenia in Patients With Spinal Metastasis: A Systematic Review and Meta-Analysis of Retrospective Cohort Studies.

Authors:  Haifeng Tan; Xiaoyu Gao; Xiaoyu Li; Yunling Huang; Qi Cao; Teng Wan
Journal:  Front Oncol       Date:  2022-04-05       Impact factor: 5.738

9.  Diet and Culture Among Chinese Patients Undergoing Hemodialysis: A Qualitative Study.

Authors:  Yan Song; Jing Wang; Huan Liu; Xiaolan Chen; Minqi Zhan
Journal:  Front Nutr       Date:  2022-04-25

10.  The Impact of Functional Bars and Adapted Physical Activity on Quality of Life in Chronic Kidney Disease: A Pilot Study.

Authors:  Elisa Grazioli; Eliana Tranchita; Giulia Marrone; Silvia Urciuoli; Manuela Di Lauro; Claudia Cerulli; Nicolò Piacentini; Arianna Murri; Roberto Celotto; Annalisa Romani; Attilio Parisi; Nicola Di Daniele; Annalisa Noce
Journal:  Int J Environ Res Public Health       Date:  2022-03-10       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.